LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms.

Osorio-Llanes, Estefanie / Villamizar-Villamizar, Wendy / Ospino Guerra, María Clara / Díaz-Ariza, Luis Antonio / Castiblanco-Arroyave, Sara Camila / Medrano, Luz / Mengual, Daniela / Belón, Ricardo / Castellar-López, Jairo / Sepúlveda, Yanireth / Vásquez-Trincado, César / Chang, Aileen Y / Bolívar, Samir / Mendoza-Torres, Evelyn

Pharmaceuticals (Basel, Switzerland)

2023  Volume 16, Issue 8

Abstract: The search for new drugs with the potential to ensure therapeutic success in the treatment of cardiovascular diseases has become an essential pathway to follow for health organizations and committees around the world. In June 2021, the World Health ... ...

Abstract The search for new drugs with the potential to ensure therapeutic success in the treatment of cardiovascular diseases has become an essential pathway to follow for health organizations and committees around the world. In June 2021, the World Health Organization listed cardiovascular diseases as one of the main causes of death worldwide, representing 32% of them. The most common is coronary artery disease, which causes the death of cardiomyocytes, the cells responsible for cardiac contractility, through ischemia and subsequent reperfusion, which leads to heart failure in the medium and short term. Metformin is one of the most-used drugs for the control of diabetes, which has shown effects beyond the control of hyperglycemia. Some of these effects are mediated by the regulation of cellular energy metabolism, inhibiting apoptosis, reduction of cell death through regulation of autophagy and reduction of mitochondrial dysfunction with further reduction of oxidative stress. This suggests that metformin may attenuate left ventricular dysfunction induced by myocardial ischemia; preclinical and clinical trials have shown promising results, particularly in the setting of acute myocardial infarction. This is a review of the molecular and pharmacological mechanisms of the cardioprotective effects of metformin during myocardial ischemia-reperfusion injury.
Language English
Publishing date 2023-08-09
Publishing country Switzerland
Document type Journal Article ; Review
ZDB-ID 2193542-7
ISSN 1424-8247
ISSN 1424-8247
DOI 10.3390/ph16081121
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top